Vaccine Testing Center, Johns Hopkins & NIH Celebrate 10-Year Collaboration
A shared mission to reduce the global health threat of dengue viruses and other cousins of the Zika virus family is what brought together researchers from the UVM Vaccine Testing Center, the Johns Hopkins Bloomberg School of Public Health, and the National Institute of Allergy and Infectious Diseases (NIAID) in late 2008. On June 29, members of the three collaborating institutions gathered for a celebratory ten-year anniversary dinner at Vermont's Inn at Shelburne Farms.
The consortium is led by UVM Vaccine Testing Center Director and Chair of Microbiology and Molecular Genetics Beth Kirkpatrick, M.D., Stephen Whitehead, Ph.D., senior scientist and virologist at the Laboratory of Viral Diseases at the NIAID, and Anna Durbin, M.D., professor of international health at the Johns Hopkins Bloomberg School of Public Health. In addition to this ongoing collaboration, the UVM team has garnered additional funding from the National Institutes of Health and the Bill & Melinda Gates Foundation to examine ways to prevent and gain a better understanding of dengue virus infections.